Precision Medicine Quarterly

About adminpmls2016

This author has not yet filled in any details.
So far adminpmls2016 has created 203 blog entries.

Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service

2023-04-12T14:47:20-05:00April 12th, 2023|

As clinical whole-genome sequencing (WGS) is becoming more of a routine diagnostic test for certain patients with genetic disorders, the Broad Institute has launched a new end-to-end WGS and variant interpretation service in partnership with genome analysis company Fabric Genomics. Priced at $1,000 per sample, the new test promises to be competitive with other [...]

Agilent, PathAI Forge Deal on Algorithm-Supported Assay Development

2023-04-12T14:29:16-05:00April 12th, 2023|

Agilent Technologies and digital pathology firm PathAI are partnering to develop assays and distribute PathAI's software and algorithms to anatomic pathology laboratories, they announced on Wednesday. Santa Clara, California-based Agilent and Boston-based PathAI said the multiyear deal covers the development of assays, including companion diagnostics and digital pathology tests. "This partnership brings together our [...]

New Lung Cancer Evolution, Treatment Response Patterns Emerge From TRACERx Study

2023-04-12T14:26:06-05:00April 12th, 2023|

New results from the UK's Tracking Cancer Evolution through Therapy (TRACERx) study are providing a close look at the evolution of non-small cell lung cancer including intratumor heterogeneity (ITH), treatment-related tumor adaptations, tumor features influencing disease progression and metastasis, immune interactions, and other tumor evolutionary clues related to clinical outcomes. The prospective, multicenter TRACERx [...]

Foundation Medicine, Bristol Myers Squibb Expand CDx Partnership to Investigational Cancer Drug

2023-04-12T14:21:18-05:00April 12th, 2023|

Foundation Medicine said Tuesday that it has expanded an ongoing collaboration with Bristol Myers Squibb to include companion diagnostic development for the pharma firm's investigational tyrosine kinase inhibitor repotrectinib. Repotrectinib is an orally administered tyrosine kinase inhibitor that is being evaluated in an ongoing registrational Phase I/II trial called TRIDENT-1 for patients with TKI-naive [...]

Illumina, Henry Ford Health Partner on Genomic Testing for Cardiovascular Patients

2023-04-12T14:18:14-05:00April 12th, 2023|

Illumina and Henry Ford Health said on Tuesday that they have launched a partnership to study the impact of whole-genome sequencing in cardiovascular disease.Under the terms of the deal, Henry Ford's centers for precision medicine and genomic medicine in Detroit will conduct implementation and clinical studies to investigate the use of next-generation sequencing tests, including [...]

New NASEM Report Suggests Dropping Race, Ethnicity Tags From Genetic, Genomic Studies

2023-03-15T08:16:03-05:00March 15th, 2023|

Researchers should reconsider how they use population descriptors such as race, ethnicity, and geographic location in genomic and genetic research, according to a new report from the US National Academies of Sciences, Engineering, and Medicine. The report, commissioned by the National Institutes of Health, says population descriptors do not fully capture the range of [...]

New Single-Cell Genome, Transcriptome Sequencing Technique Delivers Better Bang For Buck

2023-03-15T08:07:05-05:00March 15th, 2023|

A scalable and low-cost way to perform genome and transcriptome sequencing (G&T-seq) of single cells without upfront whole-genome amplification (WGA) is being developed at Belgium's KU Leuven. The method, called Gtag&T-seq (Gtag), combines G&T-seq with tagmentation. Researchers from the lab of Thierry Voet at KU Leuven used it to improve coverage uniformity, lower selection [...]

Sophia Genetics, Agilent Partner on Cancer Analysis Product

2023-03-15T08:05:17-05:00March 15th, 2023|

Sophia Genetics said Tuesday that it is integrating its DDM bioinformatics platform with Agilent Technologies' recently released SureSelect Cancer Comprehensive Genomic Profiling (CGP) assay kit. By bringing together Sophia's analytics with Agilent's target enrichment and next-generation sequencing-based assay technology, the firms hope this partnership will help cancer researchers improve identification of multiple biomarkers. "We [...]

Polygenic Risk Score, AI Tool May Help Patients Reduce Inherited Heart Disease Risk, Study Suggests

2023-03-08T08:33:57-05:00March 8th, 2023|

An artificial intelligence tool paired with a polygenic risk score (PRS) can quantify steps for patients to take to curb their inherited risk of coronary artery disease, according to late-breaking clinical trial results shared Sunday at the American College of Cardiology (ACC) and World Congress of Cardiology's annual scientific meeting. Study authors from the [...]

Go to Top